参考文献/References:
[1] Du B, Xu J, Hu J, et al. A clinical study of the intra-neuro-endoscopic technique for the treatment of subacute-chronicand chronic septal subdural hematoma [J]. Front Neurol, 2019, 10: 1408.
[2] Balser D, Farooq S, Mehmood T, et al. Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations [J]. J Neurosurg, 2015, 123(5): 1209-1215.
[3] Court J, Touchette CJ, Iorio-Morin C, et al. Embolization of the Middle meningeal artery in chronic subdural hema-toma--a systematic review [J]. Clin Neurol Neurosurg, 2019, 186: 105464.
[4] Kolias AG, Chari A, Santarius T, et al. Chronic subdural haematoma: modern management and emerging therapies[J]. Nat Rev Neurol, 2014, 10(10): 570-578.
[5] Takahashi S, Yamauchi T, Yamamura T, et al. Proposal of treatment strategies for bilateral chronic subdural hema-toma based on laterality of treated hematoma [J]. Asian JNeurosurg, 2018, 13(4): 1134-1139.
[6] Saito H, Tanaka M, Hadeishi H. Angiogenesis in the septumand inner membrane of refractory chronic subdural hema-tomas: consideration of findings after middle meningeal artery embolization with low-concentration n-butyl-2-cyanoacrylate [J]. NMC Case Rep J, 2019, 6(4): 105-110.
[7] Jumah F, Osama M, Islim A I, et al. Efficacy and safety of middle meningeal artery embolization in the management of refractory or chronic subdural hematomas: a systematic review and meta-analysis [J]. Acta Neurochir (Wien), 2020, 162(3): 499-507.
[8] Miller JD, Nader R. Acute subdural hematoma from bridg-ing vein rupture: a potential mechanism for growth [J]. J Neurosurg, 2014, 120(6): 1378-1384.
[9] Shim YS, Park CO, Hyun DK, et al. What are the causative factors for a slow, progressive enlargement of a chronic subdural hematoma [J]. Yonsei Med J, 2007, 48(2): 210-217.
[10] Osuka K, Watanabe Y, Usuda N, et al. Activation of Ras/MEK/ERK signaling in chronic subdural hematoma outer membranes [J]. Brain Res, 2012, 1489: 98-103.
[11] Frati A, Salvati M, Mainiero F, et al. Inflammation markers and risk factors for recurrence in 35 patients with a post-traumatic chronic subdural hematoma: a prospective study [J]. J Neurosurg, 2004, 100(1): 24-32.
[12] Toi H, Kinoshita K, Hirai S, et al. Present epidemiology of chronic subdural hematoma in Japan: analysis of 63,358 cases recorded in a national administrative database [J]. J Neurosurg, 2018, 128(1): 222-228.
[13] Nakaguchi H, Tanishima T, Yoshimasu N. Factors in the natural history of chronic subdural hematomas that influ-ence their postoperative recurrence [J]. J Neurosurg, 2001, 95(2): 256-262.
[14] Han MH, Ryu JI, Kim CH, et al. Predictive factors for recur-rence and clinical outcomes in patients with chronic sub-dural hematoma [J]. J Neurosurg, 2017, 127(5): 1117-1125.
[15] Mori K, Maeda M. Surgical treatment of chronic subduralhematoma in 500 consecutive cases: clinical characteristics,surgical outcome, complications, and recurrence rate [J]. Neurol Med Chir (Tokyo), 2001, 41(8): 371-381.
[16] Stanisic M, Lund-Johansen M, Mahesparan R. Treatment of chronic subdural hematoma by burr-hole craniostomy in adults: influence of some factors on postoperative recurrence[J]. Acta Neurochir (Wien), 2005, 147(12): 1249-1257.
[17] Matsumoto H, Hanayama H, Okada T, et al. Clinical inves-tigation of refractory chronic subdural hematoma: a compa-rison of clinical factors between single and repeated recurr-ences [J]. World Neurosurg, 2017, 107: 706-715.
[18] Mandai S, Sakurai M, Matsumoto Y. Middle meningealartery embolization for refractory chronic subdural hema-toma: case report [J]. J Neurosurg, 2000, 93(4): 686-688.
[19] Link TW, Schwarz JT, Paine SM, et al. Middle meningeal artery embolization for recurrent chronic subdural hema-toma: a case series [J]. World Neurosurg, 2018, 118: 570-574.
[20] Fantoni M, Eliezer M, Serrano F, et al. High frequency of ophthalmic origin of the middle meningeal artery in chronic subdural hematoma [J]. Neuroradiology, 2020, 62(5): 639-644.
[21] Waqas M, Vakhari K, Weimer PV, et al. Safety and effec-tiveness of embolization for chronic subdural hematoma: systematic review and case series [J]. World Neurosurg, 2019, 126: 228-236.
[22] Kim E. Embolization therapy for refractory hemorrhage in patients with chronic subdural hematomas [J]. World Neurosurg, 2017, 101: 520-527.
[23] Link TW, Boddu S, Paine SM, et al. Middle meningeal arteryembolization for chronic subdural hematoma: a series of 60 cases [J]. Neurosurgery, 2019, 85(6): 801-807.
[24] Gaynor BG, Elhammady MS, Jethanamest D, et al. Inci-dence of cranial nerve palsy after preoperative embolization of glomus jugulare tumors using Onyx [J]. J Neurosurg, 2014, 120(2): 377-381.
[25] Kang J, Whang K, Hong SK, et al. Middle meningeal artery embolization in recurrent chronic subdural hematoma combined with arachnoid cyst [J]. Korean J Neurotrauma, 2015, 11(2): 187-190.
[26] Ban SP, Hwang G, Byoun HS, et al. Middle meningeal arteryembolization for chronic subdural hematoma [J]. Radiology, 2018, 286(3): 992-999.
[27] Chihara H, Imamura H, Ogura T, et al. Recurrence of arefractory chronic subdural hematoma after middle menin-geal artery embolization that required craniotomy [J]. NMC Case Rep J, 2014, 1(1): 1-5.
相似文献/References:
[1]谢宝树 张 林 王 宇 贾 锋 殷玉华.复发性多发胶质母细胞瘤的预后分析[J].中国临床神经外科杂志,2016,(06):333.[doi:10.13798/j.issn.1009-153X.2016.06.005]
XIE Bao-shu,ZHANG Lin,WANG Yu,et al.Analysis of prognoses in patients with recurrent multiple glioblastomas[J].,2016,(04):333.[doi:10.13798/j.issn.1009-153X.2016.06.005]
[2]庞陆军 张恒柱 李育平 严正村 王杏东 魏 民.慢性硬膜下血肿术前影像学分型和手术治疗[J].中国临床神经外科杂志,2016,(02):101.[doi:10.13798/j.issn.1009-153X.2016.02.014]
[3]王林风 郑华山 操 廉 李庆阳 贾俊峰 丁 磊 张 武.钻孔引流术治疗慢性硬膜下血肿90例[J].中国临床神经外科杂志,2016,(02):109.[doi:10.13798/j.issn.1009-153X.2016.02.018]
[4]王 斌 杨秀莹.高位颅骨钻孔引流术治疗慢性硬膜下血肿[J].中国临床神经外科杂志,2016,(02):115.[doi:10.13798/j.issn.1009-153X.2016.02.021]
[5]孙成法 姜 华 褚荣涛 金 科.671例慢性硬膜下血肿的临床分析[J].中国临床神经外科杂志,2016,(01):42.[doi:10.13798/j.issn.1009-153X.2016.01.015]
[6]陈 新 张传玲 王伟功.锥颅引流术与钻孔冲洗引流术治疗慢性硬膜下血肿的疗效对比分析[J].中国临床神经外科杂志,2016,(01):53.[doi:10.13798/j.issn.1009-153X.2016.01.020]
[7]黄海源 颜庆华 张 猛 丁兴进 刘 枫 沈建华 史 俊.慢性硬膜下血肿钻孔引流术中持续冲洗的临床效果[J].中国临床神经外科杂志,2016,(01):55.[doi:10.13798/j.issn.1009-153X.2016.01.021]
[8]闫 进 李 松 杨 辉.1H-MRS对卵泡刺激素免疫阳性垂体腺瘤的诊断和预后评估的价值[J].中国临床神经外科杂志,2015,(10):588.[doi:10.13798/j.issn.1009-153X.2015.10.004]
YAN Jin,LI Song,YANG Hui..Value of 1H-MRS to diagnosis and assessment of prognoses in patients with non-functioning gonadotroph adenomas[J].,2015,(04):588.[doi:10.13798/j.issn.1009-153X.2015.10.004]
[9]宋贵东 综述 高之宪 审校.贝伐单抗治疗复发胶质母细胞瘤的研究进展[J].中国临床神经外科杂志,2015,(10):638.[doi:10.13798/j.issn.1009-153X.2015.10.022]
[10]曾昭戎.慢性硬膜下血肿钻孔引流术中尿激酶的应用体会[J].中国临床神经外科杂志,2015,(08):491.[doi:10.13798/j.issn.1009-153X.2015.08.017]